Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Safety, Tolerability and the Pharmacokinetics of Ridinilazole in Adolescent Subjects

ClinicalTrials.gov ID: NCT04802837

Public ClinicalTrials.gov record NCT04802837. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 9:28 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double Blind, Active Controlled Study to Evaluate the Safety and Tolerability of Ridinilazole Compared With Vancomycin and to Assess the Pharmacokinetics of Ridinilazole in Adolescent Subjects (Aged 12 to <18 Years) With Clostridioides Difficile Infection

Study identification

NCT ID
NCT04802837
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Summit Therapeutics
Industry
Enrollment
2 participants

Conditions and interventions

Interventions

  • Ridinilazole Drug
  • Vancomycin Drug

Drug

Eligibility (public fields only)

Age range
12 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 18, 2021
Primary completion
Sep 16, 2021
Completion
Sep 27, 2022
Last update posted
Aug 20, 2023

2021 – 2022

United States locations

U.S. sites
18
U.S. states
10
U.S. cities
14
Facility City State ZIP Site status
University of California, Los Angeles (UCLA) David Geffen School of Medicine Los Angeles California 90095
Children's Hospital Orange County Orange California 92868
Continental Clinical Research Miami Florida 33144
Dynamic Medical Research LLC Miami Florida 33144
D&H National Research Centers Miami Florida 33155
HMD Research Orlando Florida 32819
Children's Center for Digestive Health Atlanta Georgia 30342
Snake River Research Idaho Falls Idaho 83404
Ann and Robert H Lurie Children's Hospital of Chicago Chicago Illinois 60611
University of Chicago - Comer Children's Hospital Chicago Illinois 60637
Indiana University Health - Riley Hospital for Children Indianapolis Indiana 46202
Boston Children's Hospital Boston Massachusetts 02115
Children's Hospital of Michigan Detroit Michigan 48201
Icahn School of Medicine at Mount Sinai New York New York 10029
DiGiovanna Institute for Medical Education and Research New York New York 11758
Stony Brook University Medical Center Stony Brook New York 11794
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229
University Hospitals Cleveland Medical Center - Rainbow Babies and Children's Hospital Cleveland Ohio 44106

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04802837, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 20, 2023 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04802837 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →